logo

Last Update

This profile was last updated on 2/12/2016 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Roger Aamodt?

Roger L. Aamodt

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Background Information

Employment History

Chief, Resources Develpment Branch

National Cancer Institute


Web References(3 Total References)


Climate Change Blog: Climate Skeptic Slap Down: the Earth is Demonstrably Heating

www.climateark.org [cached]

Roger L. Aamodt, PhD
National Cancer Institute


2005 Annual Meeting - American Association for Cancer Research

services.aacr.org [cached]

Chairperson: Roger L. Aamodt, National Cancer Institute, Rockville, MD


Brisk trade in tissue for proteomics and genomics research - College of American Pathologists

www.cap.org [cached]

"We basically make tissue available to people who call and ask, and pharmaceutical and clinical diagnostics companies have access as long as they are doing research and not incorporating the tissues into product development," says Roger Aamodt, PhD, chief of the NCI's Resources Development Branch and president of the International Society for Biological and Environmental Repositories.While NCI is in close contact with the big pharmaceutical companies, it has no formal relationship with them."We feel we're serving pretty much a different constituency," Dr. Aamodt says.But commercial and academic researchers can use NCI's specimen resource locator or "tissue expediter," which functions as a single point of contact for researchers looking for tissues.In many cases, researchers don't have any other means of learning about these tissues because they're not commercially available.A more elaborate effort underway at NCI is the Shared Pathology Informatics Network, or SPIN, which will use state-of-the-art informatics techniques to establish an Internet-based virtual database."This will allow researchers to query a large number of institutions' electronic clinical information systems and pull out a listing of what pathology specimens are there that will meet their research needs," Dr. Aamodt says."Law regarding ownership of specimens is very complicated and confusing at this point," Dr. Aamodt says.The California Supreme Court, in Moore v. Regents of the University of California, ruled in 1990 that a patient does not have a continuing ownership interest in his excised cells and tissue used in research.However, the court also held that the failure to inform a patient that his collected tissue would be used for research purposes was a breach of the duty to obtain informed consent.More rigorous rules will take effect April 14, Dr. Aamodt says."The regulation of tissue banking is the same as rules applying to any other human subject research, and the Department of Health and Human Services is about to implement new rules under the Health Insurance Portability and Accountability Act.These rules will significantly strengthen privacy and confidentiality controls,probably with some major negative impact on research," he says.Most tissue research is considered to pose "minimal risk" to patients, but the new privacy rules have extensive administrative requirements that apply whether or not there is a determination of increased risk.If it is health data and is identifiable, then it requires additional administrative procedures."Because the rules are very complicated, it will take the research community some time to fully understand what they mean and how they apply," Dr. Aamodt says.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory